ETH Whales Dump ~$900M as ETF Selling Threatens Ethereum Crash
Ethereum (ETH) is facing renewed selling pressure after whales offloaded about 550,000 ETH (≈$880M) in one week, pushing price below nearby support at $1,633. The later update also links the move to ETF outflows: ETF investors reportedly sold about $270M in a week as ETH slid toward the $1,500 area.
Key levels traders are watching: $1,583 is highlighted as a critical volume support (URPD). If ETH loses $1,583, the article warns it could open a “clear path for extended liquidations.” Further downside risk is flagged for the $1,237–$1,089 range, where a new cycle low could form.
Technicals remain range-bound: support is near $1,500 and resistance sits around $1,700. Bulls likely need a breakout above $1,700, while bears want a decisive move under $1,500.
Despite the bearish near-term backdrop, some corporate buyers are accumulating ETH. Bitmine/SharpLink reportedly resumed buying, adding 29,196 ETH (≈$46.7M; over $62M in the past three days). However, ETH whales and ETF selling dominate the narrative, making support defense around $1,583 crucial for preventing liquidation cascades.
Bearish
This news is bearish for ETH specifically because the supply shock from whales and the additional sell pressure from ETF outflows raise the probability of support failure. The articles emphasize that ETH is already below key levels ($1,633, then $1,583 URPD). If $1,583 breaks, the liquidation-sensitive setup can accelerate price declines in the short term.
In the near term, traders are likely to act defensively around $1,583–$1,500: failing to hold support may trigger cascading liquidations and keep ETH capped under resistance near $1,700. Over the longer horizon, if downside extends into the $1,237–$1,089 band, it can signal a deeper cycle low risk.
While corporate accumulation (Bitmine/SharpLink adding ETH) is a constructive counterpoint, the summaries conclude that it is currently insufficient to offset whale distribution and ETF selling. That imbalance keeps the overall price impact tilted downward.